Head of Pfizer booed by Trump supporters
Pfizer, Haemophilia B and The Nikkei
Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...
Prolific NYC real estate investor David Werner has finally completed the complex real estate puzzle underpinning his planned ...
All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...
Medicare changes will cut $1 billion from 2025 revenue, with Pfizer now responsible for 20% of catastrophic drug costs. Read ...
Pfizer is doubling down on its fight against cancer with a 60-second ad set to air during the first quarter of the game.
Mylan, which has an established presence in the central nervous system therapy segment, is expected to leverage its network ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...
We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback